WFA
GMAB icon

Wipfli Financial Advisors’s Genmab GMAB Stock Holding History

Wipfli Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$171K Buy
+5,313
New +$187K 0.01% 497

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wipfli Financial Advisors's GMAB Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Genmab (GMAB) in Q3 2022: 5,313 shares worth $171K. The stake represents 0.01% of the portfolio and ranks #497 among its holdings.

193 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Wipfli Financial Advisors held 5,313 shares of Genmab worth $171K as of Q3 2022.
  • Genmab was a new Wipfli Financial Advisors position in Q3 2022.
  • Genmab made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #497 holding.
  • 193 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.